With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
Author: Gwen Smith
FDA’s Relaxed Label Rules: Updates Fail to Silence Allergy Concerns
The Food and Drug Administration recently updated its guidance on a temporary food labeling policy that has been causing widespread… Read more »
Palforzia OIT Study Sees Maturing of Immune System Over Time
A study found encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial participants… Read more »
Food Allergy and Asthma: the Burden on the Black Community
Updated January 2022 – Discussions about systemic racial bias have gained prominence in the past few years, and health care… Read more »
Kaléo Announces Relaunch in Canada of Allerject Auto-Injector
The compact Allerject epinephrine auto-injector will relaunch across the Canada as of May 19, the pharmaceutical maker Kaléo has announced.… Read more »
Experts Revise Anaphylaxis Emergency Plan for COVID-19
The standard recommendation for anyone experiencing anaphylaxis is: administer epinephrine promptly in the reaction, and call 9-1-1 to have an… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
Study Shows High Costs and Burden of Peanut Allergy
A study of a large U.S. health insurer database reveals the high dollar and health costs for those living with… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Peanut Patch Therapy Led to Big Quality of Life Improvement for Families
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »